PINTO ALEXIS (Chief Legal Officer) sold 82.1% of their position (30K shares) of ZENTALIS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $2.33M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+30K
Price / share
$34.40
Trade value
$1.03M
% of position
Common Stock
Shares
−1.80K
Price / share
$76.10
Trade value
$136.97K
% of position
Common Stock
Shares
−8.10K
Price / share
$77.27
Trade value
$625.73K
% of position
Common Stock
Shares
−19.80K
Price / share
$78.05
Trade value
$1.55M
% of position
Common Stock
Shares
−300.00
Price / share
$78.85
Trade value
$23.66K
% of position
Net shares
+0.00
Net value
-$1.30M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/25/2021 | M · Option Exercise | +30K | $34.40 | $1.03M | 459.7% | 6.53K | 36.53K |
| Common Stock Direct | 10/25/2021 | S · Sale | −1.80K | $76.10 | $136.97K | 4.9% | 36.53K | 34.73K |
| Common Stock Direct | 10/25/2021 | S · Sale | −8.10K | $77.27 | $625.73K | 23.3% | 34.73K | 26.63K |
| Common Stock Direct | 10/25/2021 | S · Sale | −19.80K | $78.05 | $1.55M | 74.4% | 26.63K | 6.83K |
| Common Stock Direct | 10/25/2021 | S · Sale | −300.00 | $78.85 | $23.66K | 4.4% | 6.83K | 6.53K |
| Total | +0.00 | -$1.30M | ||||||
Stock Option (Right to Buy)
Common Stock
30K shares
Shares
−30K
Strike price
34.4
Held after
245K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock30K shares | 10/25/2021 | M · Option Exercise | −30K | 34.4 | — | 245K |